BioPharma Resources

Investigational drug · Phase 2

PG043

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Open Angle Glaucoma, Ocular Hypertension.

Phase 2

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

0 still active

All registered trials

1

Any phase or sponsor naming "PG043"

First trial start

2024

Sep 4, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "PG043", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Open Angle Glaucoma
  • Ocular Hypertension

Approved drugs for the same conditions: High blood pressure (hypertension) · Glaucoma · Cardiovascular and metabolic · Ophthalmology

Largest trials

Live from ClinicalTrials.gov: studies naming "PG043" as an intervention, largest first.

All trials
  • Next Generation RocklatanPivotal-lookingCompleted

    Alcon ResearchIndustry

    NCT06441643 · 646 participants · Start Sep 4, 2024 · Primary completion Nov 14, 2025

    Drug: AR-17043 Ophthalmic Solution; PG043 Ophthalmic Solution and 4 more · For: Open Angle Glaucoma; Ocular Hypertension

    Sites: Dothan, Alabama; Phoenix, Arizona; Garden Grove, California · 25 sites in all

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Open Angle Glaucoma

  • NCX 470NCX 470 0.1%Phase 32 trials

    Nicox Ophthalmics, Inc. · Open Angle Glaucoma, Ocular Hypertension

  • AR-17043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.